NIH investigators create new protein for HIV; New tech penetrates blood-brain barrier;

> NIH investigators have created a protein that "awakens" resting immune cells infected with HIV, helping spur their destruction in laboratory studies. Release

> A team of investigators has used a nasal mucosal grafting technology to smuggle therapies past the brain-blood barrier, providing some new options for treating ailments in the brain. Release

> Sanford Burnham Prebys Medical Discovery Institute researchers led a collaborative study that merged together two public databases, developing a new catalog of "cancer drivers" for investigators to inspect. Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.